This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iwakura, K. Articles by Fujii, K. Search for Related Content PubMed PubMed Citation Articles by Iwakura, K. Articles by Fujii, K.

Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction

Katsuomi Iwakura, MD^*, Hiroshi Ito, MD, FACC^*,*, Masashi Ikushima, MD^*, Shigeo Kawano, MD^*, Atsushi Okamura, MD^*, Katsuaki Asano, MD^*, Tadashi Kuroda, MD^*, Koji Tanaka, MD^*, Tohru Masuyama, MD, Masatsugu Hori, MD and Kenshi Fujii, MD^*

^* Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka University, Osaka, Japan
Department of Internal Medicine and Therapeutics, Graduate School of Medicine, Osaka University, Osaka, Japan

View larger version (26K): [in a new window]   Figure 1 Relationship between peak creatine kinase (CK) value and wall motion score (WMS) in patients with or without hyperglycemia. Both patients with hyperglycemia (open circles) and those without it (solid squares) showed a weak but significant relationship between peak CK and WMS (r = 0.35, p = 0.002 and r = 0.28, p = 0.04, respectively). The hyperglycemia group showed a significantly lower WMS, even after adjusting for differences in peak CK (p = 0.009 by analysis of covariance).